Aju IB Investment

Aju IB Investment

Aju IB Investment

Follow us
Alexa global traffic share
Latest investments Show all
$50,000,000
Venture capital (Series B)
Kezar Life Sciences
$47,100,000
Venture capital (Series D)
Apellis Pharma
Team Size
1–10
Employees
Past year's investments

Aju IB Investment participated in fewer than 3 rounds over the past year

Latest rounds
  • Kezar Life Sciences: Venture capital (Series B) ($50M)
  • Apellis Pharma: Venture capital (Series D) ($47.1M)
  • Bellicum Pharma: Venture capital (Series C) ($94.4M)